158 related articles for article (PubMed ID: 18572881)
1. Chemical and biological profiles of novel copper(II) complexes containing S-donor ligands for the treatment of cancer.
Giovagnini L; Sitran S; Montopoli M; Caparrotta L; Corsini M; Rosani C; Zanello P; Dou QP; Fregona D
Inorg Chem; 2008 Jul; 47(14):6336-43. PubMed ID: 18572881
[TBL] [Abstract][Full Text] [Related]
2. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
3. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
Giovagnini L; Sitran S; Castagliuolo I; Brun P; Corsini M; Zanello P; Zoleo A; Maniero A; Biondi B; Fregona D
Dalton Trans; 2008 Dec; (47):6699-708. PubMed ID: 19153618
[TBL] [Abstract][Full Text] [Related]
4. Zinc(II) complexes with dithiocarbamato derivatives: structural characterisation and biological assays on cancerous cell lines.
Nagy EM; Sitran S; Montopoli M; Favaro M; Marchiò L; Caparrotta L; Fregona D
J Inorg Biochem; 2012 Dec; 117():131-9. PubMed ID: 23085593
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
Miernicka M; Szulawska A; Czyz M; Lorenz IP; Mayer P; Karwowski B; Budzisz E
J Inorg Biochem; 2008 Feb; 102(2):157-65. PubMed ID: 17868889
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of cis-platinum(II) cycloaliphatic amidine complexes: Ring size and solvent effects on the biological activity.
Marzano C; Sbovata SM; Gandin V; Michelin RA; Venzo A; Bertani R; Seraglia R
J Inorg Biochem; 2009 Aug; 103(8):1113-9. PubMed ID: 19560209
[TBL] [Abstract][Full Text] [Related]
10. Systematic coordination chemistry and cytotoxicity of copper(II) complexes with methyl substituted 4-nitropyridine N-oxides.
Puszko A; Brzuszkiewicz A; Jezierska J; Adach A; Wietrzyk J; Filip B; Pełczynska M; Cieslak-Golonka M
J Inorg Biochem; 2011 Aug; 105(8):1109-14. PubMed ID: 21726775
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structure and biological activities of copper(II) complexes with chelating bidentate 2-substituted benzimidazole ligands.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Grünert R; Gdaniec M; Tabin P
J Inorg Biochem; 2006 Aug; 100(8):1389-98. PubMed ID: 16740312
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic and cytotoxic studies of the novel designed palladium(II) complexes: beta-lactoglobulin and K562 as the targets.
Divsalar A; Saboury AA; Yousefi R; Moosavi-Movahedi AA; Mansoori-Torshizi H
Int J Biol Macromol; 2007 Mar; 40(4):381-6. PubMed ID: 17097727
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Gdaniec M
Arch Pharm (Weinheim); 2007 Jul; 340(7):333-8. PubMed ID: 17611942
[TBL] [Abstract][Full Text] [Related]
14. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.
Marzano C; Pellei M; Alidori S; Brossa A; Lobbia GG; Tisato F; Santini C
J Inorg Biochem; 2006 Feb; 100(2):299-304. PubMed ID: 16387362
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure and biological activity of copper(II) complexes of 4-(2-pyridylmethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione and 4-(2-pyridylethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione.
Singh AP; Kaushik NK; Verma AK; Hundal G; Gupta R
Eur J Med Chem; 2009 Apr; 44(4):1607-14. PubMed ID: 18775587
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral activity of non-platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2005 Dec; 48(25):7925-31. PubMed ID: 16335917
[TBL] [Abstract][Full Text] [Related]
17. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
[TBL] [Abstract][Full Text] [Related]
18. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
19. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Kedziora J; Klimczak A; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):52-6. PubMed ID: 19391508
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
Tan C; Liu J; Chen L; Shi S; Ji L
J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
